Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children
- 1 November 2001
- journal article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 139 (5), 682-688
- https://doi.org/10.1067/mpd.2001.118428
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Whole Blood Clot Lysis in Newborns and Adults after Adding Different Concentrations of Recombinant Tissue Plasminogen Activator (Rt-PA)Seminars in Thrombosis and Hemostasis, 1998
- Use of Tissue Type Plasminogen Activator in Neonates: Case Reports and Review of the LiteratureAmerican Journal of Perinatology, 1996
- Thrombolysis of a modified Blalock-Taussig shunt with recombinant tissue plasminogen activator in a newborn infant with pulmonary atresia and ventricular septal defect.Heart, 1994
- Extended deep vein and inferior vena cava thrombosis in a 15-year-old boy: Successful lysis with recombinant tissue-type plasminogen activator 2 weeks after onset of symptomsEuropean Journal of Pediatrics, 1993
- Recombinant tissue plasminogen activator for neonatal and pediatric vascular thrombolytic therapyJournal of Pediatric Surgery, 1993
- Successful use of low-dose tissue plasminogen activator for treatment of thrombosed prosthetic valve in a 22-month-old childAmerican Heart Journal, 1992
- Thrombolysis with tissue-type plasminogen activator following cardiac surgery in childrenInternational Journal of Cardiology, 1992
- Diagnosis of neonatal aortic thrombosis by colour coded Doppler sonographyPediatric Radiology, 1992
- Tissue plasminogen activator for the treatment of thromboembolism in infants and childrenThe Journal of Pediatrics, 1991
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988